As a result of the above-mentioned shortfalls, the present study has aimed at the dynamic simulation at the molecular level and molecular docking studies on taxifolin targeting W80R mutant protein in protein kinase B/serine-threonine kinase/AKT1 protein of Ovarian cancer for designing therapeutic. This evidence concerns the gene AKT1 and ovarian carcinoma.